Report cover image

Global Next Generation Cancer Diagnostics Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750310

Description

Global Next Generation Cancer Diagnostics Databank Market Report


The Next Generation Cancer Diagnostics market was valued at $8,704.9 Million in 2022, and is projected to reach $18,019.9 Million by 2031 growing at a CAGR of 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR of 8.60%. DNA Microarrays segment is anticipated to reach $1,017.6 Million by 2031 with the highest CAGR of 13.67%. Next-Generation Sequencing and qPCR & Multiplexing segments collectively expected to account for about 73.4% share of the Next Generation Cancer Diagnostics market in 2022, with the former constituting around 49.9% share. DNA Microarrays and Protein Microarrays segments are expected to witness significant growth rates at a CAGR of 13.67% and 9.96% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 7.6% in the overall Next Generation Cancer Diagnostics market in 2022, and is anticipated to reach 10.1% by 2031.

Table of Contents

100 Pages
1. Global Next Generation Cancer Diagnostics Market, By Technology
1.1. Overview
1.2. Next-Generation Sequencing
1.2.1 Next-Generation Sequencing Market, By Region
1.2.1.1 North America Next-Generation Sequencing Market, By Country
1.2.1.2 Europe Next-Generation Sequencing Market, By Country
1.2.1.3 Asia-Pacific Next-Generation Sequencing Market, By Country
1.2.1.4 Rest of World Next-Generation Sequencing Market, By Country
1.3. qPCR & Multiplexing
1.3.1 qPCR & Multiplexing Market, By Region
1.3.1.1 North America qPCR & Multiplexing Market, By Country
1.3.1.2 Europe qPCR & Multiplexing Market, By Country
1.3.1.3 Asia-Pacific qPCR & Multiplexing Market, By Country
1.3.1.4 Rest of World qPCR & Multiplexing Market, By Country
1.4. Lab-on- a- chip
1.4.1 Lab-on- a- chip Market, By Region
1.4.1.1 North America Lab-on- a- chip Market, By Country
1.4.1.2 Europe Lab-on- a- chip Market, By Country
1.4.1.3 Asia-Pacific Lab-on- a- chip Market, By Country
1.4.1.4 Rest of World Lab-on- a- chip Market, By Country
1.5. Protein Microarrays
1.5.1 Protein Microarrays Market, By Region
1.5.1.1 North America Protein Microarrays Market, By Country
1.5.1.2 Europe Protein Microarrays Market, By Country
1.5.1.3 Asia-Pacific Protein Microarrays Market, By Country
1.5.1.4 Rest of World Protein Microarrays Market, By Country
1.6. DNA Microarrays
1.6.1 DNA Microarrays Market, By Region
1.6.1.1 North America DNA Microarrays Market, By Country
1.6.1.2 Europe DNA Microarrays Market, By Country
1.6.1.3 Asia-Pacific DNA Microarrays Market, By Country
1.6.1.4 Rest of World DNA Microarrays Market, By Country
2. Global Next Generation Cancer Diagnostics Market, By Application
2.1. Overview
2.2. Biomarker Development
2.2.1 Biomarker Development Market, By Region
2.2.1.1 North America Biomarker Development Market, By Country
2.2.1.2 Europe Biomarker Development Market, By Country
2.2.1.3 Asia-Pacific Biomarker Development Market, By Country
2.2.1.4 Rest of World Biomarker Development Market, By Country
2.3. CTC Analysis
2.3.1 CTC Analysis Market, By Region
2.3.1.1 North America CTC Analysis Market, By Country
2.3.1.2 Europe CTC Analysis Market, By Country
2.3.1.3 Asia-Pacific CTC Analysis Market, By Country
2.3.1.4 Rest of World CTC Analysis Market, By Country
2.4. Proteomic Analysis
2.4.1 Proteomic Analysis Market, By Region
2.4.1.1 North America Proteomic Analysis Market, By Country
2.4.1.2 Europe Proteomic Analysis Market, By Country
2.4.1.3 Asia-Pacific Proteomic Analysis Market, By Country
2.4.1.4 Rest of World Proteomic Analysis Market, By Country
2.5. Epigenetic Analysis
2.5.1 Epigenetic Analysis Market, By Region
2.5.1.1 North America Epigenetic Analysis Market, By Country
2.5.1.2 Europe Epigenetic Analysis Market, By Country
2.5.1.3 Asia-Pacific Epigenetic Analysis Market, By Country
2.5.1.4 Rest of World Epigenetic Analysis Market, By Country
2.6. Genetic Analysis
2.6.1 Genetic Analysis Market, By Region
2.6.1.1 North America Genetic Analysis Market, By Country
2.6.1.2 Europe Genetic Analysis Market, By Country
2.6.1.3 Asia-Pacific Genetic Analysis Market, By Country
2.6.1.4 Rest of World Genetic Analysis Market, By Country
3. Global Next Generation Cancer Diagnostics Market, By Cancer Type
3.1. Overview
3.2. Lung Cancer
3.2.1 Lung Cancer Market, By Region
3.2.1.1 North America Lung Cancer Market, By Country
3.2.1.2 Europe Lung Cancer Market, By Country
3.2.1.3 Asia-Pacific Lung Cancer Market, By Country
3.2.1.4 Rest of World Lung Cancer Market, By Country
3.3. Breast Cancer
3.3.1 Breast Cancer Market, By Region
3.3.1.1 North America Breast Cancer Market, By Country
3.3.1.2 Europe Breast Cancer Market, By Country
3.3.1.3 Asia-Pacific Breast Cancer Market, By Country
3.3.1.4 Rest of World Breast Cancer Market, By Country
3.4. Colorectal Cancer
3.4.1 Colorectal Cancer Market, By Region
3.4.1.1 North America Colorectal Cancer Market, By Country
3.4.1.2 Europe Colorectal Cancer Market, By Country
3.4.1.3 Asia-Pacific Colorectal Cancer Market, By Country
3.4.1.4 Rest of World Colorectal Cancer Market, By Country
3.5. Cervical Cancer
3.5.1 Cervical Cancer Market, By Region
3.5.1.1 North America Cervical Cancer Market, By Country
3.5.1.2 Europe Cervical Cancer Market, By Country
3.5.1.3 Asia-Pacific Cervical Cancer Market, By Country
3.5.1.4 Rest of World Cervical Cancer Market, By Country
3.6. Other Cancer Types
3.6.1 Other Cancer Types Market, By Region
3.6.1.1 North America Other Cancer Types Market, By Country
3.6.1.2 Europe Other Cancer Types Market, By Country
3.6.1.3 Asia-Pacific Other Cancer Types Market, By Country
3.6.1.4 Rest of World Other Cancer Types Market, By Country
4. Global Next Generation Cancer Diagnostics Market, By Function
4.1. Overview
4.2. Therapeutic Monitoring
4.2.1 Therapeutic Monitoring Market, By Region
4.2.1.1 North America Therapeutic Monitoring Market, By Country
4.2.1.2 Europe Therapeutic Monitoring Market, By Country
4.2.1.3 Asia-Pacific Therapeutic Monitoring Market, By Country
4.2.1.4 Rest of World Therapeutic Monitoring Market, By Country
4.3. Companion Diagnostics
4.3.1 Companion Diagnostics Market, By Region
4.3.1.1 North America Companion Diagnostics Market, By Country
4.3.1.2 Europe Companion Diagnostics Market, By Country
4.3.1.3 Asia-Pacific Companion Diagnostics Market, By Country
4.3.1.4 Rest of World Companion Diagnostics Market, By Country
4.4. Prognostics
4.4.1 Prognostics Market, By Region
4.4.1.1 North America Prognostics Market, By Country
4.4.1.2 Europe Prognostics Market, By Country
4.4.1.3 Asia-Pacific Prognostics Market, By Country
4.4.1.4 Rest of World Prognostics Market, By Country
4.5. Cancer Screening
4.5.1 Cancer Screening Market, By Region
4.5.1.1 North America Cancer Screening Market, By Country
4.5.1.2 Europe Cancer Screening Market, By Country
4.5.1.3 Asia-Pacific Cancer Screening Market, By Country
4.5.1.4 Rest of World Cancer Screening Market, By Country
4.6. Risk Analysis
4.6.1 Risk Analysis Market, By Region
4.6.1.1 North America Risk Analysis Market, By Country
4.6.1.2 Europe Risk Analysis Market, By Country
4.6.1.3 Asia-Pacific Risk Analysis Market, By Country
4.6.1.4 Rest of World Risk Analysis Market, By Country
5. Global Next Generation Cancer Diagnostics Market, By Region
5.1. Overview
5.2. North America
5.2.1 North America Next Generation Cancer Diagnostics Market, By Technology
5.2.2 North America Next Generation Cancer Diagnostics Market, By Application
5.2.3 North America Next Generation Cancer Diagnostics Market, By Cancer Type
5.2.4 North America Next Generation Cancer Diagnostics Market, By Function
5.2.5 North America Next Generation Cancer Diagnostics Market, By Country
5.2.5.1 U.S.
5.2.5.1.1 U.S. Next Generation Cancer Diagnostics Market, By Technology
5.2.5.1.2 U.S. Next Generation Cancer Diagnostics Market, By Application
5.2.5.1.3 U.S. Next Generation Cancer Diagnostics Market, By Cancer Type
5.2.5.1.4 U.S. Next Generation Cancer Diagnostics Market, By Function
5.2.5.2 Canada
5.2.5.2.1 Canada Next Generation Cancer Diagnostics Market, By Technology
5.2.5.2.2 Canada Next Generation Cancer Diagnostics Market, By Application
5.2.5.2.3 Canada Next Generation Cancer Diagnostics Market, By Cancer Type
5.2.5.2.4 Canada Next Generation Cancer Diagnostics Market, By Function
5.3. Europe
5.3.1 Europe Next Generation Cancer Diagnostics Market, By Technology
5.3.2 Europe Next Generation Cancer Diagnostics Market, By Application
5.3.3 Europe Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.4 Europe Next Generation Cancer Diagnostics Market, By Function
5.3.5 Europe Next Generation Cancer Diagnostics Market, By Country
5.3.5.1 Germany
5.3.5.1.1 Germany Next Generation Cancer Diagnostics Market, By Technology
5.3.5.1.2 Germany Next Generation Cancer Diagnostics Market, By Application
5.3.5.1.3 Germany Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.1.4 Germany Next Generation Cancer Diagnostics Market, By Function
5.3.5.2 U.K.
5.3.5.2.1 U.K. Next Generation Cancer Diagnostics Market, By Technology
5.3.5.2.2 U.K. Next Generation Cancer Diagnostics Market, By Application
5.3.5.2.3 U.K. Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.2.4 U.K. Next Generation Cancer Diagnostics Market, By Function
5.3.5.3 France
5.3.5.3.1 France Next Generation Cancer Diagnostics Market, By Technology
5.3.5.3.2 France Next Generation Cancer Diagnostics Market, By Application
5.3.5.3.3 France Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.3.4 France Next Generation Cancer Diagnostics Market, By Function
5.3.5.4 Italy
5.3.5.4.1 Italy Next Generation Cancer Diagnostics Market, By Technology
5.3.5.4.2 Italy Next Generation Cancer Diagnostics Market, By Application
5.3.5.4.3 Italy Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.4.4 Italy Next Generation Cancer Diagnostics Market, By Function
5.3.5.5 Spain
5.3.5.5.1 Spain Next Generation Cancer Diagnostics Market, By Technology
5.3.5.5.2 Spain Next Generation Cancer Diagnostics Market, By Application
5.3.5.5.3 Spain Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.5.4 Spain Next Generation Cancer Diagnostics Market, By Function
5.3.5.6 Rest of Europe
5.3.5.6.1 Rest of Europe Next Generation Cancer Diagnostics Market, By Technology
5.3.5.6.2 Rest of Europe Next Generation Cancer Diagnostics Market, By Application
5.3.5.6.3 Rest of Europe Next Generation Cancer Diagnostics Market, By Cancer Type
5.3.5.6.4 Rest of Europe Next Generation Cancer Diagnostics Market, By Function
5.4. Asia-Pacific
5.4.1 Asia-Pacific Next Generation Cancer Diagnostics Market, By Technology
5.4.2 Asia-Pacific Next Generation Cancer Diagnostics Market, By Application
5.4.3 Asia-Pacific Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.4 Asia-Pacific Next Generation Cancer Diagnostics Market, By Function
5.4.5 Asia-Pacific Next Generation Cancer Diagnostics Market, By Country
5.4.5.1 China
5.4.5.1.1 China Next Generation Cancer Diagnostics Market, By Technology
5.4.5.1.2 China Next Generation Cancer Diagnostics Market, By Application
5.4.5.1.3 China Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.1.4 China Next Generation Cancer Diagnostics Market, By Function
5.4.5.2 Japan
5.4.5.2.1 Japan Next Generation Cancer Diagnostics Market, By Technology
5.4.5.2.2 Japan Next Generation Cancer Diagnostics Market, By Application
5.4.5.2.3 Japan Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.2.4 Japan Next Generation Cancer Diagnostics Market, By Function
5.4.5.3 South Korea
5.4.5.3.1 South Korea Next Generation Cancer Diagnostics Market, By Technology
5.4.5.3.2 South Korea Next Generation Cancer Diagnostics Market, By Application
5.4.5.3.3 South Korea Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.3.4 South Korea Next Generation Cancer Diagnostics Market, By Function
5.4.5.4 India
5.4.5.4.1 India Next Generation Cancer Diagnostics Market, By Technology
5.4.5.4.2 India Next Generation Cancer Diagnostics Market, By Application
5.4.5.4.3 India Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.4.4 India Next Generation Cancer Diagnostics Market, By Function
5.4.5.5 Indonesia
5.4.5.5.1 Indonesia Next Generation Cancer Diagnostics Market, By Technology
5.4.5.5.2 Indonesia Next Generation Cancer Diagnostics Market, By Application
5.4.5.5.3 Indonesia Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.5.4 Indonesia Next Generation Cancer Diagnostics Market, By Function
5.4.5.6 Rest of Asia
5.4.5.6.1 Rest of Asia Next Generation Cancer Diagnostics Market, By Technology
5.4.5.6.2 Rest of Asia Next Generation Cancer Diagnostics Market, By Application
5.4.5.6.3 Rest of Asia Next Generation Cancer Diagnostics Market, By Cancer Type
5.4.5.6.4 Rest of Asia Next Generation Cancer Diagnostics Market, By Function
5.5. Rest of World
5.5.1 Rest of World Next Generation Cancer Diagnostics Market, By Technology
5.5.2 Rest of World Next Generation Cancer Diagnostics Market, By Application
5.5.3 Rest of World Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.4 Rest of World Next Generation Cancer Diagnostics Market, By Function
5.5.5 Rest of World Next Generation Cancer Diagnostics Market, By Country
5.5.5.1 Brazil
5.5.5.1.1 Brazil Next Generation Cancer Diagnostics Market, By Technology
5.5.5.1.2 Brazil Next Generation Cancer Diagnostics Market, By Application
5.5.5.1.3 Brazil Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.5.1.4 Brazil Next Generation Cancer Diagnostics Market, By Function
5.5.5.2 Mexico
5.5.5.2.1 Mexico Next Generation Cancer Diagnostics Market, By Technology
5.5.5.2.2 Mexico Next Generation Cancer Diagnostics Market, By Application
5.5.5.2.3 Mexico Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.5.2.4 Mexico Next Generation Cancer Diagnostics Market, By Function
5.5.5.3 South Africa
5.5.5.3.1 South Africa Next Generation Cancer Diagnostics Market, By Technology
5.5.5.3.2 South Africa Next Generation Cancer Diagnostics Market, By Application
5.5.5.3.3 South Africa Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.5.3.4 South Africa Next Generation Cancer Diagnostics Market, By Function
5.5.5.4 Australia
5.5.5.4.1 Australia Next Generation Cancer Diagnostics Market, By Technology
5.5.5.4.2 Australia Next Generation Cancer Diagnostics Market, By Application
5.5.5.4.3 Australia Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.5.4.4 Australia Next Generation Cancer Diagnostics Market, By Function
5.5.5.5 ROW Countries
5.5.5.5.1 ROW Countries Next Generation Cancer Diagnostics Market, By Technology
5.5.5.5.2 ROW Countries Next Generation Cancer Diagnostics Market, By Application
5.5.5.5.3 ROW Countries Next Generation Cancer Diagnostics Market, By Cancer Type
5.5.5.5.4 ROW Countries Next Generation Cancer Diagnostics Market, By Function
ROW Countries Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 2. Next-Generation Sequencing Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Next-Generation Sequencing Market Value, By Country, 2022-2031, Million USD
TABLE 7. qPCR & Multiplexing Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World qPCR & Multiplexing Market Value, By Country, 2022-2031, Million USD
TABLE 12. Lab-on- a- chip Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Lab-on- a- chip Market Value, By Country, 2022-2031, Million USD
TABLE 17. Protein Microarrays Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Protein Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 19. Europe Protein Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 20. Asia-Pacific Protein Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 21. Rest of World Protein Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 22. DNA Microarrays Market Value, By Region, 2022-2031, Million USD
TABLE 23. North America DNA Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 24. Europe DNA Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 25. Asia-Pacific DNA Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 26. Rest of World DNA Microarrays Market Value, By Country, 2022-2031, Million USD
TABLE 27. Global Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 28. Biomarker Development Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Biomarker Development Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Biomarker Development Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Biomarker Development Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Biomarker Development Market Value, By Country, 2022-2031, Million USD
TABLE 33. CTC Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America CTC Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 35. Europe CTC Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 36. Asia-Pacific CTC Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 37. Rest of World CTC Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 38. Proteomic Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 39. North America Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 40. Europe Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 41. Asia-Pacific Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 42. Rest of World Proteomic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 43. Epigenetic Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 44. North America Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 45. Europe Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 46. Asia-Pacific Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 47. Rest of World Epigenetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 48. Genetic Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 49. North America Genetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 50. Europe Genetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 51. Asia-Pacific Genetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 52. Rest of World Genetic Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 53. Global Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 54. Lung Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 55. North America Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 56. Europe Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 57. Asia-Pacific Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 58. Rest of World Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 59. Breast Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 60. North America Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 61. Europe Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 62. Asia-Pacific Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 63. Rest of World Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 64. Colorectal Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 65. North America Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 66. Europe Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 67. Asia-Pacific Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 68. Rest of World Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 69. Cervical Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 70. North America Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 71. Europe Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 72. Asia-Pacific Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 73. Rest of World Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 74. Other Cancer Types Market Value, By Region, 2022-2031, Million USD
TABLE 75. North America Other Cancer Types Market Value, By Country, 2022-2031, Million USD
TABLE 76. Europe Other Cancer Types Market Value, By Country, 2022-2031, Million USD
TABLE 77. Asia-Pacific Other Cancer Types Market Value, By Country, 2022-2031, Million USD
TABLE 78. Rest of World Other Cancer Types Market Value, By Country, 2022-2031, Million USD
TABLE 79. Global Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 80. Therapeutic Monitoring Market Value, By Region, 2022-2031, Million USD
TABLE 81. North America Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
TABLE 82. Europe Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
TABLE 83. Asia-Pacific Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
TABLE 84. Rest of World Therapeutic Monitoring Market Value, By Country, 2022-2031, Million USD
TABLE 85. Companion Diagnostics Market Value, By Region, 2022-2031, Million USD
TABLE 86. North America Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 87. Europe Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 88. Asia-Pacific Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 89. Rest of World Companion Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 90. Prognostics Market Value, By Region, 2022-2031, Million USD
TABLE 91. North America Prognostics Market Value, By Country, 2022-2031, Million USD
TABLE 92. Europe Prognostics Market Value, By Country, 2022-2031, Million USD
TABLE 93. Asia-Pacific Prognostics Market Value, By Country, 2022-2031, Million USD
TABLE 94. Rest of World Prognostics Market Value, By Country, 2022-2031, Million USD
TABLE 95. Cancer Screening Market Value, By Region, 2022-2031, Million USD
TABLE 96. North America Cancer Screening Market Value, By Country, 2022-2031, Million USD
TABLE 97. Europe Cancer Screening Market Value, By Country, 2022-2031, Million USD
TABLE 98. Asia-Pacific Cancer Screening Market Value, By Country, 2022-2031, Million USD
TABLE 99. Rest of World Cancer Screening Market Value, By Country, 2022-2031, Million USD
TABLE 100. Risk Analysis Market Value, By Region, 2022-2031, Million USD
TABLE 101. North America Risk Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 102. Europe Risk Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 103. Asia-Pacific Risk Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 104. Rest of World Risk Analysis Market Value, By Country, 2022-2031, Million USD
TABLE 105. Global Next Generation Cancer Diagnostics Market Value, By Region, 2022-2031, Million USD
TABLE 106. North America Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 107. North America Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 108. North America Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 109. North America Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 110. North America Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 111. U.S. Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 112. U.S. Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 113. U.S. Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 114. U.S. Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 115. Canada Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 116. Canada Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 117. Canada Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 118. Canada Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 119. Europe Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 120. Europe Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 121. Europe Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 122. Europe Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 123. Europe Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 124. Germany Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 125. Germany Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 126. Germany Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 127. Germany Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 128. U.K. Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 129. U.K. Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 130. U.K. Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 131. U.K. Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 132. France Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 133. France Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 134. France Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 135. France Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 136. Italy Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 137. Italy Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 138. Italy Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 139. Italy Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 140. Spain Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 141. Spain Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 142. Spain Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 143. Spain Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 144. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 145. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 146. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 147. Rest of Europe Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 148. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 149. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 150. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 151. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 152. Asia-Pacific Next Generation Cancer Diagnostics Market Value, By Country, 2022-2031, Million USD
TABLE 153. China Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 154. China Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 155. China Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 156. China Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 157. Japan Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 158. Japan Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 159. Japan Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 160. Japan Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD
TABLE 161. South Korea Next Generation Cancer Diagnostics Market Value, By Technology, 2022-2031, Million USD
TABLE 162. South Korea Next Generation Cancer Diagnostics Market Value, By Application, 2022-2031, Million USD
TABLE 163. South Korea Next Generation Cancer Diagnostics Market Value, By Cancer Type, 2022-2031, Million USD
TABLE 164. South Korea Next Generation Cancer Diagnostics Market Value, By Function, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us